Stockscreener 앱 받기
8.27
2.10%
0.17
전일 마감가:
$8.10
열려 있는:
$8.13
하루 거래량:
152.63K
Relative Volume:
0.56
시가총액:
$553.90M
수익:
$555.06M
순이익/손실:
$-39.48M
주가수익비율:
-13.78
EPS:
-0.6
순현금흐름:
$29.05M
1주 성능:
-2.82%
1개월 성능:
+7.40%
6개월 성능:
+9.83%
1년 성능:
-20.63%
1일 변동 폭
$8.13
$8.45
1주일 범위
$7.78
$9.03
52주 변동 폭
$5.81
$11.25
Bioventus Inc Stock (BVS) Company Profile
명칭
Bioventus Inc
전화
(919) 474-6700
주소
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Compare BVS vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
8.27 | 542.51M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-09 | 개시 | Barrington Research | Outperform |
| 2025-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-12-07 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2022-11-22 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2022-11-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-03-15 | 개시 | Craig Hallum | Buy |
| 2021-11-15 | 재개 | Morgan Stanley | Overweight |
| 2021-11-10 | 재개 | JP Morgan | Overweight |
| 2021-07-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-03-08 | 개시 | Canaccord Genuity | Buy |
| 2021-03-08 | 개시 | Goldman | Buy |
| 2021-03-08 | 개시 | JP Morgan | Overweight |
| 2021-03-08 | 개시 | Morgan Stanley | Overweight |
모두보기
Bioventus Inc 주식(BVS)의 최신 뉴스
Head-To-Head Review: Bioventus (BVS) vs. Its Rivals - Defense World
Chipmakers Recap: Is Bioventus Inc attractive for institutional investors2025 Valuation Update & Weekly High Return Stock Forecasts - baoquankhu1.vn
Recap Report: Is Bioventus Inc currently under institutional pressure2025 Major Catalysts & Technical Buy Zone Confirmations - baoquankhu1.vn
Bioventus (NASDAQ:BVS) Upgraded at Barrington Research - MarketBeat
Those who invested in Bioventus (NASDAQ:BVS) three years ago are up 413% - Yahoo Finance
Barrington Research Initiates Coverage of Bioventus (BVS) with Outperform Recommendation - Nasdaq
Bioventus (NYSE:BVS) Shares Gap UpWhat's Next? - MarketBeat
Bioventus (NASDAQ:BVS) Shares Gap UpHere's What Happened - MarketBeat
Barrington Initiates Bioventus at Outperform With $13 Price Target - marketscreener.com
Bioventus (NYSE:BVS) Earns Outperform Rating from Analysts at Barrington Research - MarketBeat
This Nokia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
BVS: Bioventus Receives New Analyst Rating from Barrington Resea - GuruFocus
Avoiding Lag: Real-Time Signals in (BVS) Movement - Stock Traders Daily
Is Bioventus Inc. attractive for institutional investorsJuly 2025 Snapshot & Technical Pattern Based Buy Signals - baoquankhu1.vn
Bioventus (NASDAQ:BVS) Trading Up 1.4%Here's What Happened - MarketBeat
Bioventus (NASDAQ:BVS) Trading 1.4% HigherWhat's Next? - MarketBeat
Bioventus (NASDAQ:BVS) aligns with Nasdaq Composite Index medtech themes - Kalkine Media
Anderson Financial Strategies LLC Invests $901,000 in Bioventus Inc. $BVS - MarketBeat
Aug Selloffs: Will Bioventus Inc benefit from rising consumer demand2025 Support & Resistance & Reliable Intraday Trade Plans - baoquankhu1.vn
Is Bioventus Inc currently under institutional pressureEarnings Performance Report & Weekly Top Gainers Trade List - baoquankhu1.vn
Discipline and Rules-Based Execution in BVS Response - Stock Traders Daily
US Market Recap: What is Bioventus Incs valuation compared to sectorFed Meeting & Weekly Setup with ROI Potential - baoquankhu1.vn
Entry Recap: Can CNVS maintain sales growthGap Down & Accurate Technical Buy Alerts - baoquankhu1.vn
Published on: 2026-01-23 16:18:52 - baoquankhu1.vn
Bioventus (NYSE:BVS) Trading Up 3.8%Still a Buy? - MarketBeat
Bioventus Details Turnaround Plan, Four Growth Drivers at J.P. Morgan Conference - Defense World
Bioness $110M Sale Suit Heads to $8.9M Deal - Law360
Investment Recap: Is Bioventus Inc in a bullish channel2025 Risk Factors & High Conviction Buy Zone Picks - baoquankhu1.vn
Institutional investors own a significant stake of 36% in Bioventus Inc. (NASDAQ:BVS) - Yahoo Finance
Bioventus (NASDAQ:BVS) Stock Price Down 0.6%Should You Sell? - MarketBeat
Market Catalysts: Is Bioventus Inc currently under institutional pressure2025 Winners & Losers & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Trade Recap: Is Bioventus Inc stock gaining market shareProduct Launch & Safe Capital Preservation Plans - Bộ Nội Vụ
Recent uptick might appease Bioventus Inc. (NASDAQ:BVS) institutional owners after losing 13% over the past year - simplywall.st
What Wall Street predicts for Bioventus Inc. stock priceShort Setup & Weekly Sector Rotation Insights - ulpravda.ru
Why Bioventus Inc. stock could rally in 20252025 Short Interest & Accurate Buy Signal Alerts - Улправда
Will Bioventus Inc. stock deliver consistent dividendsDay Trade & High Accuracy Trade Alerts - Улправда
Is Bioventus Inc. stock gaining market share2025 Earnings Impact & Breakout Confirmation Trade Signals - Улправда
Can Bioventus Inc. stock sustain revenue growthJuly 2025 Spike Watch & Community Consensus Stock Picks - Улправда
How risky is Bioventus Inc. stock nowJuly 2025 Setups & Free Daily Entry Point Trade Alerts - Улправда
Will Bioventus Inc. stock return to pre crisis levelsJuly 2025 Opening Moves & High Accuracy Buy Signal Tips - Улправда
Why Bioventus Inc. stock could outperform in 2025Portfolio Value Summary & Low Risk High Win Rate Picks - Улправда
Hyaluronic Acid Products Market to Reach $20 billion, Globally, - openPR.com
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
(BVS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business - MSN
Bioventus Inc. (BVS) Stock Analysis: Exploring a 101.61% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Will Bioventus Inc stock deliver consistent dividends2025 Earnings Impact & Growth Focused Investment Plans - moha.gov.vn
Bioventus (NYSE:BVS) Trading Down 1.1%Time to Sell? - MarketBeat
Why (BVS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Aug Analyst Calls: Why Bioventus Inc stock could outperform in 2025Gap Up & Weekly Breakout Opportunity Watchlist - moha.gov.vn
Why Bioventus Inc. stock is favored by top institutionsJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Улправда
Bioventus Inc (BVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.51%
자본화:
|
볼륨(24시간):